Leibniz-Institut
DSMZ-Deutsche Sammlung von
Mikroorganismen und Zellkulturen GmbH

Price Information for DSM 23047

Name:
Actinomyces massiliensis

Prices and supply forms:
The price of each culture varies depending on the delivery form. For the above mentioned culture the available delivery forms and prices are:

Delivery form Prices
Freeze Dried 100,- €
Active culture on request 240,- €
DNA 150,- € 
Price Category for this culture: 1

Banking and Handling charges (per order):
In addition to the above mentioned costs of a culture DSMZ raises a combined banking and handling fee for the complete order (independently of the number of cultures). This fees depends on the total amount of the invoice:

Invoice amount (net)EU-memberNon-EU
21-100 €5 €15 €
101-500 €10 €20 €
>501 €15 €30 €

Freight Charges per order:
Additional freight charges depend on the country, in which the culture will be delivered and the following conditions:
The price for a delivery in a certain country is listed on our website: https://www.dsmz.de/catalogues/catalogue-microorganisms/prices.html

Nagoya Protocol Restrictions:

France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.

To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:

   1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
   2. Await approval by the Ministry for the Ecological Transition, the competent national authority
   3. Respond to any requests for more information from the competent national authority
   4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.

For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de




Restrictions
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1

All prices are net prices, non-binding and subject to changes.
Our General Terms & Conditions apply to all deliveries and services (http://www.dsmz.de/terms.html).

Geschäftsführer/Managing Director:
Prof. Dr. Jörg Overmann; Bettina Fischer
Aufsichtsratsvorsitzender/Head of
Supervisory Board: MD Dr. David Schnieders
Braunschweigische Landessparkasse
Kto.-Nr./Account: 2 039 220
BLZ/Bank Code: 250 500 00
IBAN DE22 2505 0000 0002 0392 20
SWIFT (BIC) NOLADE 2 H
Handelsregister/ Commercial Register:
Amtsgericht Braunschweig
HRB 2570
Steuer-Nr. 13/200/24030